Will you have Colorectal cancer metastatic with Miralax - from FDA reports

Summary

Colorectal cancer metastatic is reported only by a few people who take Miralax. We study 47,387 people who have side effects while taking Miralax from FDA. Among them, 4 have Colorectal cancer metastatic. Find out below who they are, when they have Colorectal cancer metastatic and more.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on polyethylene glycol 3350 (the active ingredients of Miralax) and Miralax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Synonyms of Colorectal cancer metastatic are also considered in the study.

What is Miralax?

Miralax has active ingredients of polyethylene glycol 3350. It is often used in constipation. (latest outcomes from Miralax 47,992 users)

What is Colorectal cancer metastatic?

Colorectal cancer metastatic (cancer of colon and rectal spreads to other parts) has been reported by people with colorectal cancer metastatic, colon cancer, rheumatoid arthritis, high blood pressure, pain (latest reports from 16,132 Colorectal cancer metastatic patients).

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 14, 2019

47,387 people reported to have side effects when taking Miralax.
Among them, 4 people (0.01%) have Colorectal cancer metastatic


Number of reports submitted per year:

Could Miralax cause Colorectal cancer metastatic?

Gender of people who have Colorectal cancer metastatic when taking Miralax *:

  • female: 50 %
  • male: 50 %

Age of people who have Colorectal cancer metastatic when taking Miralax *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Top conditions involved for these people *:

  1. Preventive Health Care: 2 people, 50.00%
  2. Pain: 2 people, 50.00%
  3. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 2 people, 50.00%
  4. Gastritis (inflammation of stomach): 2 people, 50.00%
  5. Colon Cancer Metastatic (cancer of colon spreads to other part of body): 2 people, 50.00%
  6. Colon Cancer: 2 people, 50.00%
  7. Cellulitis (infection under the skin): 2 people, 50.00%
  8. Metastatic Pain (pain due to cancer spread): 1 person, 25.00%
  9. Cancer Pain: 1 person, 25.00%

Top co-used drugs for these people *:

  1. Zometa: 2 people, 50.00%
  2. Benadryl: 2 people, 50.00%
  3. Erbitux: 2 people, 50.00%
  4. Prilosec: 2 people, 50.00%
  5. Oxycodone: 2 people, 50.00%
  6. Tylenol: 2 people, 50.00%
  7. Levothyroxine Sodium: 1 person, 25.00%
  8. Aspirin: 1 person, 25.00%
  9. Clonazepam: 1 person, 25.00%
  10. Everolimus: 1 person, 25.00%

Top other side effects for these people *:

  1. Toxic Encephalopathy (a degenerative neurologic disorder caused by exposure to toxic substances): 2 people, 50.00%
  2. Necrotising Fasciitis (an uncommon life-threatening soft-tissue infection): 2 people, 50.00%
  3. Intestinal Fistula Infection: 2 people, 50.00%
  4. Cellulitis (infection under the skin): 2 people, 50.00%
  5. Weakness: 1 person, 25.00%
  6. Neoplasm Progression (growth of tumour): 1 person, 25.00%
  7. Neoplasm Malignant (cancer tumour): 1 person, 25.00%
  8. Mental Status Changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation): 1 person, 25.00%
  9. Blood Bilirubin Increased: 1 person, 25.00%
  10. Blood Alkaline Phosphatase Increased: 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.


Do you have Colorectal cancer metastatic while taking Miralax?

You are not alone:




Related studies

Drugs that are associated with Colorectal cancer metastatic
Colorectal cancer metastatic (232 drugs)
Could your condition cause Colorectal cancer metastatic
Colorectal cancer metastatic (137 conditions)
Miralax side effects

Browse side effects by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Browse all side effects of Miralax
a b c d e f g h i j k l m n o p q r s t u v w x y z
Compare Miralax with similar drugs


What would happen?

Predict new side effects and undetected conditions when you take Miralax and have Colorectal cancer metastatic



FDA reports used in this study


Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.